Background:Young women undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) experience greater short-term adverse events than young men. There is a scarcity of data on the short-term adverse outcomes between young Bangladeshi males and females with ACS undergoing PCI.Objectives: This study was conducted to compare the short-term outcomes of PCI between young males and females presenting with ACS. Methods: This prospective observational study was done in the Department of Cardiology, National Institute of Cardiovascular Diseases (NICVD) fromApril 2016 to March 2017. 190 young patients with ACS and undergoing PCI were enrolled. They were equally divided into two groups, group I (young females <55 years) and group II (young males <45 years). Results: The mean age of young females and males was 43.8±6.9 years and 40.1±4.3 years respectively. Young women had significantly higher risk factors of hypertension (62.1% vs 33.7%, p<0.0010) and diabetes (57.9% vs 31.6%, p<0.001) in comparison to young men. Overall, young women experienced significantly greater incidence of short-term adverse events in comparison to young men
to men, in data derived predominantly from the preintervention era. 2 Nevertheless, even following PCI, it has been observed that women had more adverse cardiovascular outcomes, a fact that has largely been attributed to their older age at presentation and greater co-morbidities. [3] [4] However, ACS is increasingly prevalent at a younger age, particularly among those of South Asian ethnicity. 5 The prevalence of ACS among young women has also increased. 6 There is disparity in the literature on the definition of "young" with respect to premature CAD and ACS, with the age cut-off varying from ≤40 to ≤55 years in various studies. [7] [8] [9] Cardiovascular disease develops 7 to 10 years later in women than in men, 10 leading to a difference in the definition of the "young" ACS patient for each gender,arising from the fundamental differences in the physiology of women and a protective effect of endogenous oestrogens against CAD. As such, "young" patients in relation to ACS have been defined in the literature as females <55 years of age, and males <45 years of age, a similar cut-off that has been adopted in this study. 8, 9, 11 Although percutaneous revascularization is generally considered to be associated with lower risk and better recovery in young patients, multiple studies have observed that younger women were more likely than men to experience adverse cardiovascular outcomes, including in-hospital and 30-day mortality, major adverse cardiac events (MACE) and bleeding, despite similarly high angiographic and procedural success. [12] [13] [14] [15] Alternatively, a few studies have observed higher MACE among young males undergoing PCI. 16 Younger women were at more than twice the risk of periprocedural complications such as coronary dissection and abrupt vessel closure, 15 possibly attributable to their smaller vessel size and increased tortuosity of coronaries. 17 Younger women were also more likely to experience bleeding complications. 12, 14, 15 The increased adverse outcomes among younger women with ACS may be further attributed to the clustering of cardiovascular risk factors and comorbidities, most notably diabetes, and also hypertension, cerebrovascular disease, renal impairment and congestive heart failure in comparison to men. 12, 14 It has been previously studied in an older Bangladeshi population, that females undergoing PCI have more adverse in-hospital outcomes in comparison to males, particularly coronary vascular injury and bleeding complications. 18 However, there are no contemporary data on gender-related differences in shortterm outcomes of young ACS patients undergoing PCI in Bangladesh. This study has been designed to investigate any disparities in the short-term outcomes (i.e. composite of in-hospital and 30-day outcomes) between young male and female ACS patients following PCI and to identify the predictors of adverse cardiovascular outcomes in young ACS patients undergoing PCI.
Methods:
This prospective observational study was conducted over a period of 1 year from April 2016 to March 2017 at the Department of Cardiology, National Institute ofCardiovascular Diseases (NICVD), Dhaka. The study complied with the Declaration of Helsinki. Prior ethical approval was obtained from the ethical review committee of NICVD. Informed written consent was taken from each patient.Young patients were defined as males <45 years and females <55 years in accordance with the literature A total of 190 young patients presenting with ACS, and undergoing PCI during index hospitalisation at NICVD were selected by purposive sampling technique, based on predefined enrollment criteria. Patients with prior MI, mechanical complications of MI, cardiogenic shock, valvular and congenital heart disease, cardiomyopathy, prior revascularization (PCI or coronary artery bypass graft), intravenous contrast allergy, serum creatinine >2mg/dl and those with bleeding disorders were excluded. Study subjects were divided into two groups on the basis of gender. Group I comprised of young females and group II comprised of young males.
Patients' demographic characteristics, risk factors, ACS typeand left ventricular (LV) ejection fraction (EF) were recorded. Coronary angiography was performed by conventional method (right femoral access) by routine operators. All angiograms were evaluated by two experienced cardiologists. Angiographic variables including Gensini Score, ACC/ AHA lesion type of culprit lesion, culprit vessel and number of diseased vessels (single, double, triple) were noted. In case of angiographically significant stenosis, ad hoc PCI to culprit artery was done. All patients were pre-treated with standard dual antiplatelet therapy (DAPT) comprising of aspirin and clopidogrel. PCI variables including stent type, stent diameter and length, periprocedural events, angiographic, procedural and clinical success were noted. Patients were then followed up for outcome variables. Follow-up comprised of two parts: Inhospital (i.e. for the entire duration of hospital stay until time of discharge) and once again at 30-days. The following inhospital outcomes were observed and recorded: Vascular access site and peri-procedural complications, bleeding, significant arrhythmias, cardiogenic shock, acute heart failure, MI related to PCI, stent thrombosis repeat revascularization, stroke and death. All patients were further followed up at the completion of 30 days following PCI and above-mentioned outcome variables were recorded, in addition to repeat-hospitalization and recurrent ischaemia. 
Results:
A total of 190 patients were studied, including 95 young females and 95 young males. The overall mean age was 41.3±5.6 years (range 18-54 years). The mean age of young females was 43.8±6.9 years and young males was 40.1±4.3 years (Table I) . A total of 52.6% STEMI, 26.3% NSTEMI and 21.1% UA patients were included with equal distribution between the two genders. Among STEMI patients, 70% were of anterior and 30% were of inferior MI. Table II shows the distribution of risk factors between the groups. Hypertension (62.1% vs 33.7%, p<0.001) and diabetes (57.9% vs. 31.6%, p,0.001) were significantly more prevalent among young females, while smoking was significantly greater among young males (70.5% vs 0%, p<0.001). Among the young females, 70 (74%) were premenopausal, and among pre-menopausal females, 63% had history of taking oral contraceptive pill (OCP). The mean percent of left ventricular (LV) ejection fraction (EF) of study patients was 46.8±10.0. Young females had significantly higher EF in comparison to young males (48.4±9.3 vs 45.1±10.4, p=0.02). Table III shows the comparison of angiographic characteristics between the two groups. Left main coronary artery (LMCA) (3.2% vs. 1.1%, p=0.61) andLeft anterior descending (LAD) (51.6% vs. 45.3%,p=0.38) were more frequently involved among young females. Young males demonstrated angiographically more severe CAD, with significantly higher numbers of ACC/AHA lesion type B2 (40% vs 25.3%, p=0.03) and C (20% vs 9.47%, p=0.03). Young males also had greater frequency of double and triple vessel disease and higher mean Gensini scores, although not statistically significant (Table III) . 
Discussion:
This prospective observational study presents the comparison of short-term outcomes of young ACS patients undergoing PCI. The mean age of young females was significantly higher than young males (43.8±6.9 vs 40.1±4.3 years, p=0.001), which were slightly higher than the patient population of the PROMETHEUS study (48.6±5.6 years vs. 48.1±6.0 years), 12 but is comparable to an Indian study by Patted, et al. (2017) . 16 The younger mean age in this study possibly reflects the earlier onset of premature atherosclerosis among South Asian populations in comparison to Western populations. 6 Equal numbers of all presentations across the spectrum of ACS were taken from both groups in order to ensure matching. The majority of this young ACS population undergoing PCI presented with ST-elevation myocardial infarction (STEMI), accounting for 52.6% of all subjects. Anterior MI was more frequent than inferior MI. These findings concur with those of an Indian study, in which an overwhelming majority of patients underwent PCI due to STEMI. 16 In contrast, however, Chandrasekhar, et al. (2016) observed in the PROMETHEUS study, that unstable angina (UA) comprised almost half of the study population (approximately 46%) and STEMI comprised only approximately one quarter. 12 This study observed that young females had higher frequencies of baseline risk factors, particularly hypertension and diabetes. Several other studies have made similar observations. 12, 14 Diabetes is a particularly strong risk factor for coronary artery disease (CAD) in women and is associated with a heightened cardiovascular mortality particularly in women <55 years (Lansky, et al., 2004) . Some studies suggest that diabetes may also negate the protective effects of estrogen on vascular function, and increase the risks of post PCI complications. 20, 21 Smoking, however, was observed exclusively among young males (70.5%). While no females reported cigarette smoking, 8.4% of them gave a history of taking smokeless tobacco. These findings concur with Indian populations 16 and some Western studies in which fewer females were known to be smokers. 2, 13 They differ from more recent studies where smoking was significantly more frequently observed among young females. 12, 14, 22 Young females had significantly better LV systolic function than young males, and angiographically less severe CAD reflected by less frequency of multivessel disease (30.5% vs 41% for young females vs males respectively) and lesser Gensini scores. These findings concur with previous studies. 12, 14 Prior studies have reported that intracoronary stents have been used less frequently among young women with ACS, although the use of DES has been more frequent among females or comparable among both genders. 12, 22 On the contrary, in our study, significantly fewer young females received a DES (81.1% vs 96.8%, p=0.001), possibly due to financial constraints. Despite this, women have been shown to derive greater benefit from DES due to reduced intimal hyperplasia, 23 and as such, a greater use of DES should be advocated.
There was no significant difference between angiographic and procedural success between the two groups, which concurs with most prior studies wherein adverse outcomes were reported, despite comparable procedural success. 13, 14 At 30 days, young females showed lesser clinical success owing to increased recurrent ischaemia, however, this was not statistically significant.
Young women had greater incidence of all the individual outcome variables studied, except stroke. They also had significantly higher rates of short-term composite adverse outcomes, predominantly due to significantly higher rates of recurrent ischaemia, bleeding and vascular access site complications. Significantly increased vascular access site complications was also observed in Lansky, et. al. (2004) 13 where 9.4% vs 2.3% was reported for young women vs men respectively. Argulian, et. al. (2006) 15 also observed similar outcomes (7.6% vs 3.5% for young women vs men respectively).
Bleeding complications in patients with ACS are a significant predictor of adverse outcomes, morbidity and mortality. 22 In particular, patients with STEMI constitute a high-risk subset of acute patients requiring urgent revascularisation on a background of aggressive pharmacological treatment including intravenous (IV) anticoagulation, IV glycoprotein IIb/IIIa inhibitors, thrombolysis and DAPT. As such, ACS patients undergoing PCI are more prone to vascular access complications which represent a source of major bleeding.
Multiple previous studies have also observed increased bleeding and vascular complications among young women, particularly those undergoing PCI for STEMI. 14,15,25, Such increased bleeding risk has been attributed to decreased coagulation reserve, potential overdose of anticoagulant or antiplatelet agents, and differences in platelet biology of women. 15, 26 Several studies have also found that younger women were more likely than men to experience periprocedural complications such as coronary dissection and abrupt vessel closure, possibly attributable to their smaller vessel size leading to difficulty in vessel manipulation and increased susceptibility to mechanical vessel injury. 15, 17, 26 Young females showed a non-significant increase in such peri-procedural complications in our study. 12 Smaller stent diameter was also a significant predictor of poor outcome on multi-variate logistic regression analysis in this study.
Estrogen, traditionally known to exert a protective effect on vascular endothelial function in pre-menopausal women, has also been suggested as a possible reason for the increased risk of vascular injury complications in younger women, given that most women <55 years old are premenopausal. 15 Estrogen may increase the level of various coagulation factors and inflammatory markers and affects vascular endothelial function and its reaction to circulating vasoactive factors. Alternatively, the protective influence of estrogen may be over-ridden by the presence of risk factors, particularly diabetes, resulting in worse outcomes for young women with ACS compared with young men. 15 (Argulian, et al., 2006) . Further studies on the presence of specific estrogen receptors and their relationship with adverse outcomes among women are warranted.
At 30 days follow up, young females reported significantly more repeat hospitalisation (6.3% vs. 1.1%, p=0.04) most likely due to significantly higher recurrent ischaemia (7.4% vs. 2.1%). Some authors have postulated that the morbidity of angiographically non-obstructive (i.e. non-atherosclerotic) CAD is greater in women, leading to recurrent angina and adverse outcomes. 23, 27 Young females had greater incidence of combined in hospital and 30-day major adverse cardiac events (MACE) in our study (4.1% vs 2.1% for young women and men respectively), which was not statistically significant (p=0.4). Lansky, et al. (2004) also observed no significant difference in major in-hospital complications constituting MACE (3.1% vs 0.6% respectively). 13 Neither did Argulian, et al. (2006) who found rates of 4.1% vs 4.0% for males and females respectively. 15 Abramson, et al. (2003) reported an adjusted relative risk of 1.78 for increased in-hospital mortality post PCI for females over males. 17 Srinivas, et al. (2007) reported a statistically significant increase of post-PCI in-hospital mortality following acute MI in young females (0.42% vs. 0.05%; p=0.0007), with female sex found to be an independent predictor of MACE. 14 Chandrasekhar, et al. (2016) reported a 90-day MACE of 9.6% for young females in comparison to 7.6% for young males. 12 In contrast to the above studies, a recent Indian study by Patted, et al. (2017) reported an insignificant increase in MACE among young males undergoing PCI in a predominantly ACS sample population. 16 Comparison of Short-term Outcomes of Percutaneous Coronary Intervention Fathima Aaysha Cader et al.
Consequent to a significantly greater bleeding risk and insignificant increase in MACE, both groups were evaluated for net adverse clinical events (NACE), a term first defined in the HORIZONS-AMI study, and found that women had significantly higher incidence of short-term NACE (10.5% vs 3.2%, p=0.04), largely owing to their increased rates of major bleeding.
On multivariate logistic regression analysis, this study showed that hypertension, diabetes, reduced ejection fraction, smaller stent diameter and female gender were independent predictors of adverse short-term outcomes in ACS patients after PCI. Both Srinivas, et al. (2007) and Lansky, et al. (2004) in their studies found that female gender was an independent predictor of mortality, vascular complications and MACE. 13, 14 The presence of greater comorbidities among females is a contributing factor to their adverse outcomes, as observed by Chandrasekhar, et al. (2016) . 12 There are many differences in mechanisms of ACS and plaque characteristics between young males and females that may be attributed to such differences in post-PCI outcome (Chandrasekhar and Mehran, 2016) . 23 These biological differences in atherosclerosis between men and women have not been entirely clarified, and further studies using intravascular ultrasound (IVUS) and optical coherence tomography (OCT) may be helpful in defining predictors of gender-based adverse outcome among young patients.
In addition to female gender, risk factors such as hypertension and diabetes mellitus also emerged as independent predictors of adverse outcome among young ACS patients undergoing PCI. Young females with ACS are known to present with a greater clustering of these risk factors in comparison to young males, and the presence of such co-morbidities, rather than female gender per se may have been responsible for their increased incidence of adverse cardiovascular outcome. Alternatively, the fact that young women have more hypertension and diabetes could also mean the presentation of ACS itself is more often than not, complicated by these co-morbidities in young women, and could be considered as a holistic clinical entity leading to adverse outcomes, rather than separate disease processes. Having said that, in order to overcome this limitation, further studies with matching of the number of hypertensive and diabetic patients among the two genders are warranted, to independently test purely for the effect of gender on adverse outcome after PCI.
Limitations:
This study was not without limitations. The study population was relatively smallsingle center study.Sampling method was non-random, so there was risk of selection bias.It was not a single operator study, therefore there may be variation in outcome according to operator expertise.
Conclusion:
This study demonstrated that young women presenting with ACS had significantly more short term adverse outcomes after PCI than young men. Despite angiographically less severe CAD, young women had significantly increased rates of recurrent ischaemia and repeat hospitalisation. They also had higher rates of MACE including death, although not statistically significant. Young women had significantly higher rates of bleeding and vascular complications, in comparison to young men, resulting in significantly greater incidence of NACE, a composite of MACE and major bleeding. Female gender, diabetes, hypertension, decreased ejection fraction and smaller stent diameter were identified as independent predictors of adverse short-term outcomes.
